Consequences of Doing What Should Not be Done in Primary Care (SOBRINA)

Miguel Hernández University of Elche

Status: Completed

Conditions: Adverse Event; Overdose

Treatments: Drug: Ibuprofen and paracetamol; Drug: paracetamol; Diagnostic Test: Prostate cancer; Drug: Antimicrobial agent; Radiation: Lumbago; Drug: Lipid-lowering drug; Drug: Non-steroidal anti-inflammatory drugs; Drug: Benzodiazepines; Drug: Mucolytic

Study type: Observational

Funder types: Other

Identifiers

NCT03482232

PI16/00816

Details and patient eligibility

About

Retrospective observational study in a random selection of 5% of digital records active between 2014 and 2017 to quantify the frequency of Do not do primary care recommendations, calculating the over-cost related to them and study reviewing a random selection of cases previously identified to determine whether patient suffered adverse events and their over-cost.

Full description

Basement: Overuse subjected patients to unnecessary risk without promoting a sufficient clinical benefit and over-cost. The Less is More Medicine movement has led to the identification of Do not do in different specialties, also in primary care.

Objective: To analyze the impact of errors (overuse rates based in Do not do recommendations) in clinical practice.

Method: Retrospective observational study in a random selection of 5% of digital records active between 2014 and 2017 to quantify the frequency of Do not do primary care recommendations, calculating the over-cost related to them. Retrospective study reviewing a random selection of cases previously identified to determine whether patient suffered adverse events and their over-cost.

Setting. Primary care in Andalucía, Aragón, Castilla La Mancha, Comunidad Valenciana, Madrid, Murcia, Navarra y País Vasco, eight autonomous communities in Spain.

Enrollment: 750,000 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• All patients visiting GPs

Exclusion criteria

• None

Trial design

750,000 participants in 2 patient groups

Patients visiting GP

Description:

All patients visiting GP. The frequency of some drugs and diagnosis tests include in the Do-Not-Do recommendations will be analyzed.

Treatment:

Drug: Lipid-lowering drug

Drug: Non-steroidal anti-inflammatory drugs

Drug: Benzodiazepines

Drug: Antimicrobial agent

Drug: Antimicrobial agent

Diagnostic Test: Prostate cancer

Radiation: Lumbago

Drug: paracetamol

Patient visiting pediatricians

Description:

All patients visiting pediatricians (0 to 14 years old). The frequency of some drugs and diagnosis tests include in the Do-Not-Do recommendations will be analyzed.

Treatment:

Drug: Mucolytic

Drug: Antimicrobial agent

Drug: Antimicrobial agent

Drug: Ibuprofen and paracetamol